Muscular weakness represents the main limiting factor of walk, functional independence and quality of life of myelopathy patients associated to HTLV-1

被引:14
作者
Caiafa, Renata Costa [1 ]
Orsini, Marco [2 ]
Felicio, Lilian R. [3 ]
Puccioni-Sohler, Marzia [1 ,4 ]
机构
[1] Univ Fed Rio de Janeiro, Posgrad Doencas Infecciosas & Parasitarias, Rio De Janeiro, RJ, Brazil
[2] Ctr Univ Augusto Motta, Posgrad Ciencias Reabilitacao, Rio De Janeiro, RJ, Brazil
[3] Univ Fed Uberlandia, Fac Fisioterapia, Av Engenheiro Dinz 1178,CP 593, BR-38400 Uberlandia, MG, Brazil
[4] Univ Fed Rio de Janeiro, Hosp Univ Gaffree & Guinle, Posgrad HIV AIDS & Hepatite Viral, Rio De Janeiro, RJ, Brazil
关键词
HAM/TSP; functional ability; gait; quality of life;
D O I
10.1590/0004-282X20160019
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
HTLV-1-associated myelopathy is a progressive disabling disease associated with gait abnormalities. Objective: To identify and quantify the main muscles affected by weakness and spasticity, their impact on gait, functional capacity and on quality of life of HTLV-1-associated myelopathy patients. Method: We evaluated lower limbs muscular strength according to the Medical Research Council scale, spasticity according to the modified Ashworth scale, daily activities according to the Barthel Index and quality of life according to the Short-Form Health Survey-36 of 26 HTLV-1-associated myelopathy patients. Results: The muscles most affected by weakness included the dorsal flexors and knee flexors. Spasticity predominated in the hip adductor muscles and in plantar flexors. Assistance for locomotion, minimal dependence in daily activities, limitations in functional capacity and physical aspects were the most common findings. Conclusion: The impairment of gait, functional dependence and quality of life were predominantly a consequence of intense muscle weakness in HTLV-1-associated myelopathy patients.
引用
收藏
页码:280 / 286
页数:7
相关论文
共 20 条
[1]  
ASHWORTH B, 1964, PRACTITIONER, V192, P540
[2]   INTERRATER RELIABILITY OF A MODIFIED ASHWORTH SCALE OF MUSCLE SPASTICITY [J].
BOHANNON, RW ;
SMITH, MB .
PHYSICAL THERAPY, 1987, 67 (02) :206-207
[3]  
Carod-Arthal FJ, 2007, NEUROLOGIA, V22, P78
[4]   Is Human T Cell Lymphotropic Type 1 (HTLV-1)-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) Syndrome a Neglected Disease? [J].
Casseb, Jorge .
PLOS NEGLECTED TROPICAL DISEASES, 2009, 3 (11)
[5]  
Ciconelli Rozana Mesquita, 1999, Rev Bras Reumatol, V39, P143
[6]  
Coutinho I., 2011, ACTA FISIATR, V18, P6, DOI [DOI 10.5935/0104-7795.20110001, 10.5935/0104-7795.20110001]
[7]  
Daniels L., 1986, Muscle testing: Techniques of manual examination
[8]   Guide of clinical management of HTLV patient:: neurological aspects [J].
de Castro-Costa, CM ;
Araújo, AQC ;
Menna-Barret, M ;
Penalva-de-Oliveira, AC .
ARQUIVOS DE NEURO-PSIQUIATRIA, 2005, 63 (2B) :548-551
[9]   Disability and determinants of gait performance in tropical spastic paraparesis/HTLV-I associated myelopathy (HAM/TSP) [J].
Franzoi, A. C. ;
Araujo, A. Q. C. .
SPINAL CORD, 2007, 45 (01) :64-68
[10]   CHRONIC MYELOPATHY ASSOCIATED WITH HUMAN T-LYMPHOTROPIC VIRUS TYPE-I (HTLV-I) [J].
GESSAIN, A ;
GOUT, O .
ANNALS OF INTERNAL MEDICINE, 1992, 117 (11) :933-946